货号:A1216705
同义名:
TLR7 agonist T7; T7
TLR7 agonist T7 is a novel Toll-like receptor 7 (TLR7) agonist, eliciting the nonspecific antitumor responses and strengthening the specific humoral and cellular immune responses.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Toll-like receptors (TLRs) are pattern recognition receptors that play an essential role in host defense against pathogens. TLRs recognize specific pathogen-associated molecular patterns (PAMPs) conserved in viruses, bacteria and other microbes[1]. TLR7 agonist T7 (1V209), a small molecule agonist of Toll-Like receptor 7 (TLR7), is chosen as a proof-of-concept immunotherapeutic. It can be conjugated with various polysaccharides to improve its efficacy, and maintain low toxicity. Intralesional administration of 1V209 reduced the growth of melanoma nodules as well as enhanced the antimelanoma effect of systemic IL-2 treatment. In mice bearing 4T1 tumors, significantly increased levels of all three cytokines (IP-10, MCP-1, and IL-6) were observed in animals administered 1V209. Furthermore, analysis of lung metastases 28 d post-treatments demonstrated that 1V209-L-NP significantly reduced metastases counts relative to saline control. Ex vivo imaging of tumors indicated that 1V209-L-NPF accumulated in the tumor and could be imaged with animal body weights remaining constant and comparable to saline-treated animals. In addition, 1V209-L-NPF is capable of reducing the production of lung metastases[2]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.78mL 0.56mL 0.28mL |
13.91mL 2.78mL 1.39mL |
27.83mL 5.57mL 2.78mL |
CAS号 | 1062444-54-5 |
分子式 | C16H17N5O5 |
分子量 | 359.34 |
SMILES Code | O=C(O)C1=CC=C(CN2C(NC3=C(N)N=C(OCCOC)N=C23)=O)C=C1 |
MDL No. | MFCD32667006 |
别名 | TLR7 agonist T7; T7 |
运输 | 蓝冰 |
InChI Key | ATISKRYGYNSRNP-UHFFFAOYSA-N |
Pubchem ID | 58019867 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry,2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|